Emerging treatments in management of prostate cancer: biomarker validation and endpoints for immunotherapy clinical trial design

por Slovin, Susan F
Publicado 2013

Immunotherapy in metastatic prostate cancer

por Slovin, Susan F.
Publicado 2016

Radium-223 and concomitant therapies: prospects and prudence

por Yeku, Oladapo, Slovin, Susan F.
Publicado 2016

Malignant priapism in metastatic prostate cancer: A late event occurring early

por Barrett-Campbell, Odeth, Petkovska, Iva, Slovin, Susan F.
Publicado 2018

RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies

por van de Stolpe, Anja, Verhaegh, Wim, Blay, Jean-Yves, Ma, Cynthia X., Pauwels, Patrick, Pegram, Mark, Prenen, Hans, De Ruysscher, Dirk, Saba, Nabil F., Slovin, Susan F., Willard-Gallo, Karen, Husain, Hatim
Publicado 2021

Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design

por Melloni, Chiara, Slovin, Susan F., Blemings, Allan, Goodman, Shaun G., Evans, Christopher P., Nilsson, Jan, Bhatt, Deepak L., Zubovskiy, Konstantin, Olesen, Tine K., Dugi, Klaus, Clarke, Noel W., Higano, Celestia S., Roe, Matthew T.
Publicado 2020

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma

por McNeel, Douglas G., Bander, Neil H., Beer, Tomasz M., Drake, Charles G., Fong, Lawrence, Harrelson, Stacey, Kantoff, Philip W., Madan, Ravi A., Oh, William K., Peace, David J., Petrylak, Daniel P., Porterfield, Hank, Sartor, Oliver, Shore, Neal D., Slovin, Susan F., Stein, Mark N., Vieweg, Johannes, Gulley, James L.
Publicado 2016

Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

por Sperger, Jamie M., Helzer, Kyle T., Stahlfeld, Charlotte N., Jiang, Dawei, Singh, Anupama, Kaufmann, Katherine R., Niles, David J., Heninger, Erika, Rydzewski, Nicholas R., Wang, Liguo, Wang, Liewei, Yang, Rendong, Ren, Yanan, Engle, Jonathan W., Huang, Peng, Kyriakopoulos, Christos E., Slovin, Susan F., Soule, Howard R., Zhao, Shuang G., Kohli, Manish, Tagawa, Scott T., Cai, Weibo, Dehm, Scott M., Lang, Joshua M.
Publicado 2023

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

por Autio, Karen A., Antonarakis, Emmanuel S., Mayer, Tina M., Shevrin, Daniel H., Stein, Mark N., Vaishampayan, Ulka N., Morris, Michael J., Slovin, Susan F., Heath, Elisabeth I., Tagawa, Scott T., Rathkopf, Dana E., Milowsky, Matthew I., Harrison, Michael R., Beer, Tomasz M., Balar, Arjun V., Armstrong, Andrew J., George, Daniel J., Paller, Channing J., Apollo, Arlyn, Danila, Daniel C., Graff, Julie N., Nordquist, Luke, Dayan Cohn, Erica S., Tse, Kin, Schreiber, Nicole A., Heller, Glenn, Scher, Howard I.
Publicado 2021